Peptide questions · Ecnoglutide

How long does ecnoglutide take to work?

Reviewed Evidence: EstablishedPublished by PepVault

Ecnoglutide’s onset is days–2 weeks, its peak effect comes at 48 weeks (phase 3, no plateau), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

The timeline’s basis: Phase 3 SLIMMER (Ji 2025, Lancet Diabetes Endocrinol), phase 3 in type 2 diabetes (Zhu 2026, Nat Commun; He 2025, Lancet Diabetes Endocrinol), approvals (Shirley 2026, Drugs), Sciwind release Mar-6-2026, interaction studies (Chen 2026; Li 2026). The Chinese label was not read.

Ecnoglutide week by week

The library places six of its research notes on ecnoglutide on the days they cover, from day 1 to day 336 and on: 5 on randomized trials and 1 on clinical data.

Day 1 is the first day of a run. Each bar is one of the library’s research notes, placed on the days it covers.

The ecnoglutide notes by day
WhenThe noteEvidence
Days 1–28 (weeks 1–4)A low first monthRandomized trial
Days 29–56 (weeks 5–8)Doubling to 0.6 mgRandomized trial
Days 57–336 (weeks 9–48)The lowest weight-loss doseRandomized trial
Days 85–336 (weeks 13–48)The middle doseRandomized trial
Days 85–336 (weeks 13–48)The top doseRandomized trial
From day 337 onA long-term medicine, not a courseClinical data
A smiling man in a grey t-shirt in his living room, holding his phone

Model. Individual results vary.

PepVault for iPhone

Track ecnoglutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

The ecnoglutide timeline’s milestones

The library’s timeline for ecnoglutide marks 5 points from week 1 to week 48, backed by clinical trial data overall.

  • Week 1: Commonly reported: appetite dropping in the first days on 0.3 mg
  • Week 4: The diabetes trials doubled the dose to 0.6 mg at week 4
  • Week 8: And to 1.2 mg at week 8
  • Week 40: SLIMMER endpoint: about 9% (1.2 mg) to 13% (2.4 mg) average loss vs about 0% on placebo
  • Week 48: Sciwind: about 15% average loss at 2.4 mg, still falling

The weeks are the library’s reference timeline from studies and reported use, not a promise of what any one person will notice.

Why ecnoglutide takes that long

Ecnoglutide’s half-life is about 5.5 days (132 hours), so one dose is about 96.9% cleared after 28 days.

On its schedule (Weekly) the doses overlap, and the level of ecnoglutide keeps climbing for about 22–28 days before it levels off, so the first 22–28 days run below the level the later weeks hold.

The notes on ecnoglutide follow the trials’ dose steps, 0.3mg, 0.6mg, 1.2mg, 1.8mg and 2.4mg, so the later weeks also describe higher steps than the first ones; these are steps from studies, not a schedule for a person.

Ecnoglutide against other metabolic & GLP-1 compounds

The library holds an onset-and-peak timeline for 21 metabolic & GLP-1 compounds, ecnoglutide among them; 15 of the others share its onset of days–2 weeks.

When metabolic & GLP-1 compounds start to act and peak, by the library’s timelines
CompoundOnsetPeak effect
SemaglutideDays–2 weeks60–68 weeks
TirzepatideDays–2 weeks72+ weeks
RetatrutideDays–2 weeks48+ weeks
DulaglutideDays–2 weeks24–52 weeks (glucose)
ExenatideFirst dose (after-meal glucose)24–30 weeks (HbA1c)
Setmelanotide1–2 weeks (hunger)52 weeks (BMI)
OrforglipronDays–2 weeks72 weeks (trial endpoint)
SurvodutideDays–2 weeks76 weeks (trial endpoint)
MazdutideDays–2 weeks48–60 weeks
PemvidutideDays–2 weeks48+ weeks
CagrilintideDays–2 weeks26–68 weeks (trial endpoints)
PramlintideFirst meal (fullness, after-meal glucose)16–52 weeks (weight, HbA1c)
CagriSemaDays–2 weeks68+ weeks
EloralintideDays–2 weeks48 weeks (phase 2 endpoint)
PetrelintideDays–2 weeks42 weeks (phase 2, still falling)
AmycretinDays–2 weeks36 weeks (longest trial so far)
VK2735Days–2 weeks78 weeks (phase 3 endpoint, not yet read out)
EnicepatideDays–2 weeks48 weeks (phase 2 endpoint, no plateau)
EcnoglutideDays–2 weeks48 weeks (phase 3, no plateau)
EfinopegdutideWeeks24–52 weeks (trial endpoints)
SLU-PP-332Unknown in peopleUnknown in people

Questions people ask

How long does ecnoglutide take to work?

Ecnoglutide’s onset is days–2 weeks, its peak effect comes at 48 weeks (phase 3, no plateau), and its typical duration is ongoing, by the library’s timeline (backed by clinical trial data).

When does ecnoglutide reach its peak effect?

By the library’s timeline, ecnoglutide’s peak effect comes at 48 weeks (phase 3, no plateau), backed by clinical trial data.

How long is ecnoglutide usually run?

The library’s timeline gives ecnoglutide’s typical duration as ongoing; its cycle note says: Used continuously, once weekly, in its trials: 40 to 48 weeks in obesity and up to 52 weeks in type 2 diabetes, with the dose doubled every 4 weeks up to the maintenance dose.

What does the library say about the first days on ecnoglutide?

Its first note on ecnoglutide, for days 1–28 (weeks 1–4), is “A low first month”, resting on randomized trials.

More on ecnoglutide

Track it in the app

PepVault for iPhone

Track ecnoglutide in PepVault

Log each dose and your weekly check-ins, and see your own weeks add up.

Download on the App Store

7 days free on the yearly plan for new subscribers.

Explore the live demo